首页> 美国卫生研究院文献>Current Controlled Trials in Cardiovascular Medicine >ATLANTIS: a randomised multi-arm phase II biomarker-directed umbrella screening trial of maintenance targeted therapy after chemotherapy in patients with advanced or metastatic urothelial cancer

【2h】

ATLANTIS: a randomised multi-arm phase II biomarker-directed umbrella screening trial of maintenance targeted therapy after chemotherapy in patients with advanced or metastatic urothelial cancer

机译：ATLANTIS：一项针对晚期或转移性尿路上皮癌患者化疗后维持靶向治疗的随机多臂II期生物标记物指导伞筛选试验

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

Study design for patients in ATLANTIS trial. : MET proto-oncogene, progression-free survival, vascular endothelial growth factor

机译：ATLANTIS试验中患者的研究设计。：MET原癌基因，无进展生存期，血管内皮生长因子

著录项

期刊名称 Current Controlled Trials in Cardiovascular Medicine
作者
Ben Fulton; Robert Jones; Thomas Powles; Simon Crabb; James Paul; Alison Birtle; Simon Chowdhury; Syed Hussain; Anna Morris; Eileen Soulis; Paula Morrison;
展开▼
作者单位

展开▼
年(卷),期 2020(21),-1
年度 2020
页码 -1
总页数 7
原文格式 PDF
正文语种
中图分类心血管疾病;
关键词
Urothelial cancer; Precision medicine; Biomarker;

机译：尿道癌;精密医学;生物标志物;

相似文献

外文文献
中文文献
专利

1. 来自一项艾日布林联合吉西他滨对比紫杉醇联合吉西他滨作为HER2阴性转移性乳腺癌的一线化疗的II期、多中心、随机试验的包含神经病变相关量表的生活质量结果:韩国癌症研究组试验(KCSG BR13-11) [J] . Ji-Yeon Kim, Young-Hyuck Im, Tae-Yong Kim, 癌症（英文版） . 2019,第008期
2. ATLANTIS: a randomised multi-arm phase II biomarker-directed umbrella screening trial of maintenance targeted therapy after chemotherapy in patients with advanced or metastatic urothelial cancer [J] . Ben Fulton, Robert Jones, Thomas Powles, Trials . 2020,第1期

机译：亚特兰蒂斯：一种随机多臂期II生物标志物 - 导向伞形伞形疗养疗效治疗治疗治疗后的晚期或转移性尿路上皮癌的患者
3. Maintenance therapy with vinflunine plus best supportive care versus best supportive care alone in patients with advanced urothelial carcinoma with a response after first-line chemotherapy (MAJA; SOGUG 2011/02): a multicentre, randomised, controlled, open-label, phase 2 trial (vol 18, pg 672, 2017) [J] . Garcia-Donas J., Font A., Perez-Valderrama B. The lancet oncology . 2019,第1期

机译：Vinflunine的维护疗法加上最佳支持性护理与单独的尿路上皮癌患者的最佳支持性护理（Maja; Sogug 2011/02）：多期，随机，受控，开放标签，第2期试验（Vol 18，PG 672,2017）
4. Maintenance therapy with vinflunine plus best supportive care versus best supportive care alone in patients with advanced urothelial carcinoma with a response after first-line chemotherapy (MAJA; SOGUG 2011/02): a multicentre, randomised, controlled, open-label, phase 2 trial [J] . Garcia-Donas Jesus, Font Albert, Perez-Valderrama Begona, The lancet oncology . 2017,第5期

机译：Vinflunine的维护疗法加上最佳支持性护理与单独的尿路上皮癌患者的最佳支持性护理（Maja; Sogug 2011/02）：多期，随机，受控，开放标签，第2期试验
5. Locoregional hyperthermia in combination with chemotherapy for metastatic breast cancer patients: The Mammatherm- trial [C] . J.K. Jueckstock, B. Eberhardt, H.L. Sommer World congress on medical physics and biomedical engineering;International congress of the IUPESM . 2011

机译：局部热疗联合化疗治疗转移性乳腺癌患者：Mammatherm-试验
6. Supportive Care for Patients with Breast Cancer by Using an Interactive App During Neoadjuvant Chemotherapy: A Randomized Controlled Trial [D] . Fjell, Maria. 2021

机译：通过在Neoadjuvant化疗期间使用互动性应用的乳腺癌患者的支持性护理：随机对照试验
7. Randomized Phase II/III Trial Assessing Gemcitabine/ Carboplatin and Methotrexate/Carboplatin/Vinblastine in Patients With Advanced Urothelial Cancer Unfit for Cisplatin-Based Chemotherapy: Phase II—Results of EORTC Study 30986 [O] . Maria De Santis, Joaquim Bellmunt, Graham Mead, -1

机译：晚期吉林他滨/卡铂和甲氨蝶呤/甲氨蝶呤/卡铂/长春碱对不适合顺铂化疗的晚期尿路上皮癌患者的II / III期随机试验：II期-EORTC研究30986的结果
8. Maintenance therapy with vinflunine plus best supportive care versus best supportive care alone in patients with advanced urothelial carcinoma with a response after first-line chemotherapy (MAJA; SOGUG 2011/02): a multicentre, randomised, controlled, open-label, phase 2 trial [O] . Jesus García-Donas, Albert Font, Begoña Pérez-Valderrama, 2017

机译：Vinflunine加上血管内癌的维护治疗与先进的尿路上皮癌的患者相比，在一线化疗后的反应（Maja; Sogug 2011/02）：多期，随机，受控，开放标签，第2阶段试验中的最佳支持性护理

ATLANTIS: a randomised multi-arm phase II biomarker-directed umbrella screening trial of maintenance targeted therapy after chemotherapy in patients with advanced or metastatic urothelial cancer

摘要

著录项

相似文献

相关主题

期刊订阅